Observational Program Neo-Penotran® Forte

CompletedOBSERVATIONAL
Enrollment

13,024

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

April 30, 2015

Conditions
Vaginal CandidiasisBacterial VaginosisTrichomonal Vaginitis
Interventions
DRUG

Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)

Patients older than 18 years with previously taken decision of their gynecologist to prescribe Neo-Penotran Forte according to registered indications, and microbiological tests were performed.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY